Lumigan is a prescription eye drop used to lower intraocular pressure in patients with glaucoma or ocular hypertension. Its active ingredient, bimatoprost, is a synthetic prostaglandin analog that mimics natural prostaglandin activity. Bimatoprost increases the outflow of aqueous humor through the uveoscleral pathway, reducing pressure inside the eye. By enhancing fluid drainage, the medication helps preserve optic nerve function and slow disease progression. The drug is administered once daily in the evening, with a single drop placed in the affected eye(s). Clinical studies have shown that regular use consistently achieves measurable reductions in intraocular pressure over time.

Lumigan is a prescription eye drop used to treat elevated pressure inside the eye. It belongs to a class of drugs known as prostaglandin analogs that mimic natural hormone-like substances. The active ingredient, bimatoprost, binds to specific receptors in the eye's drainage tissues to enhance fluid outflow. Activation of these receptors increases the permeability of the trabecular meshwork and stimulates the uveoscleral pathway. As a result, aqueous humor drains more efficiently, leading to a measurable reduction in intraocular pressure. This action helps manage conditions such as open-angle glaucoma and ocular hypertension. The drug's effect on prostaglandin receptors provides a direct pharmacologic means to lower eye pressure without altering fluid production.

Lumigan may cause eye irritation which is a common side effect. It can also lead to mild burning or stinging upon application. Some users report blurred vision shortly after using the medication. Redness of the eye is frequently observed. Dryness of the ocular surface may occur in some patients. Itching or itchiness around the eyes can also be experienced.

Lumigan may cause mild eye irritation when applied to the eyelid. Some users report temporary redness or itching of the ocular surface. Blurred vision can occur shortly after administration, usually resolving on its own. Dryness of the eye may be experienced, leading to a sensation of grittiness. Changes in eyelash length, thickness, or pigmentation are occasionally noted. Headache or mild facial discomfort has been reported by a small number of patients. Increased intraocular pressure might be observed in rare cases but is generally transient.